Your browser doesn't support javascript.
loading
Reversibility of Diffusion-Weighted Imaging Lesions in Patients With Ischemic Stroke in the WAKE-UP Trial.
Scheldeman, Lauranne; Wouters, Anke; Bertels, Jeroen; Dupont, Patrick; Cheng, Bastian; Ebinger, Martin; Endres, Matthias; Fiebach, Jochen B; Gerloff, Christian; Muir, Keith W; Nighoghossian, Norbert; Pedraza, Salvador; Simonsen, Claus Z; Thijs, Vincent; Thomalla, Götz; Lemmens, Robin.
Afiliación
  • Scheldeman L; Department of Neurology, University Hospitals Leuven, Belgium (L.S., A.W., R.L.).
  • Wouters A; Department of Neurosciences, Experimental Neurology KU Leuven (L.S., A.W., R.L.), University of Leuven, Belgium.
  • Bertels J; Center for Brain and Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium (L.S., A.W., R.L., J.B.).
  • Dupont P; Department of Neurology, University Hospitals Leuven, Belgium (L.S., A.W., R.L.).
  • Cheng B; Department of Neurosciences, Experimental Neurology KU Leuven (L.S., A.W., R.L.), University of Leuven, Belgium.
  • Ebinger M; Center for Brain and Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium (L.S., A.W., R.L., J.B.).
  • Endres M; Department of Neurology, Amsterdam University Medical Centers, the Netherlands (A.W.).
  • Fiebach JB; Processing Speech and Images, Department of Electrial Engineering (J.B.), University of Leuven, Belgium.
  • Gerloff C; Center for Brain and Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium (L.S., A.W., R.L., J.B.).
  • Muir KW; Department of Neurosciences, Laboratory for Cognitive Neurology KU Leuven (P.D.), University of Leuven, Belgium.
  • Nighoghossian N; Leuven Brain Institute, Belgium (P.D.).
  • Pedraza S; Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, University Medical Center Hamburg-Eppendorf, Germany (B.C., C.G., G.T.).
  • Simonsen CZ; Center for Stroke Research Berlin (CSB) Charit. - Universit.tsmedizin Berlin, Germany (M. Ebinger, M. Endres, J.B.F.).
  • Thijs V; Klinik für Neurologie, Medical Park Berlin Humboldtmühle, Germany (M. Ebinger).
  • Thomalla G; Klinik und Hochschulambulanz für Neurologie, Charit. - Universit.tsmedizin Berlin, Germany (M. Endres).
  • Lemmens R; German Center for Cardiovascular Research (DZHK), partner site Berlin (M. Endres).
Stroke ; 54(6): 1560-1568, 2023 06.
Article en En | MEDLINE | ID: mdl-37158080
BACKGROUND: Reversibility of the diffusion-weighted imaging (DWI) lesion means that not all of the DWI lesion represents permanently injured tissue. We investigated DWI reversibility and the association with thrombolysis, reperfusion and functional outcome in patients from the WAKE-UP trial (Efficacy and Safety of Magnetic Resonance Imaging-Based Thrombolysis in Wake-Up Stroke). METHODS: In this retrospective analysis of WAKE-UP, a randomized controlled trial (RCT) between September 2012 and June 2017 in Belgium, Denmark, France, Germany, Spain and United Kingdom, a convolutional neural network segmented the DWI lesions (b=1000 s/mm2) at baseline and follow-up (24 hours). We calculated absolute and relative DWI reversibility in 2 ways: first, a volumetric (baseline volume-24-hour volume >0) and second, a voxel-based (part of baseline lesion not overlapping with 24-hour lesion) approach. We additionally defined relative voxel-based DWI-reversibility >50% to account for coregistration inaccuracies. We calculated the odds ratio for reversibility according to treatment arm. We analyzed the association of reversibility with excellent functional outcome (modified Rankin Scale score of 0-1), in a multivariable model. RESULTS: In 363 patients, the median DWI volume was 3 (1-10) mL at baseline and 6 (2-20) mL at follow-up. Volumetric DWI reversibility was present in 19% (69/363) with a median absolute reversible volume of 1 mL (0-2) or 28% (14-50) relatively. Voxel-based DWI reversibility was present in 358/363 (99%) with a median absolute volume of 1 mL (0-2), or 22% (9-38) relatively. In 18% of the patients (67/363), relative voxel-based DWI reversibility >50% was present. Volumetric DWI reversibility and relative voxel-based DWI reversibility >50% was more frequent in patients treated with alteplase versus placebo (OR, 1.86 [95% CI, 1.09-3.17] and OR, 2.03 [95% CI, 1.18-3.50], respectively). Relative voxel-based DWI reversibility >50% was associated with excellent functional outcome (OR, 2.30 [95% CI, 1.17-4.51]). CONCLUSIONS: Small absolute volumes of DWI reversibility were present in a large proportion of randomized patients in the WAKE-UP trial. Reversibility was more often present after thrombolysis.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Accidente Cerebrovascular / Accidente Cerebrovascular Isquémico Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Stroke Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Accidente Cerebrovascular / Accidente Cerebrovascular Isquémico Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Stroke Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos